SCHEMBL3569657

SCHEMBL3569657

CCNC(=O)c1cccnc1NCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 1/20 0.54
CHIA Q9BZP6 1/20 0.53
MAPT P10636 5/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 1/20 0.47
GLA P06280 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDR P35968 4/20 0.46
P2RX7 Q99572 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27863532 0.87 CHIA (0.53) KDM4EALDH1A1HPGDHSD17B10CHIA
SCHEMBL6168326 0.83 DHODH (0.58) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL2122993 0.82 ALDH1A1 (0.77) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL11492008 0.81 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL5418289 0.80 P2RX7 (0.70) KDM4EHPGDCHIAKMT2AHTT
SCHEMBL164540 0.80 CHIA (0.56) KDM4EHPGDCHIAKMT2AHTT
SCHEMBL6653582 0.80 CHIA (0.56) KDM4EHPGDCHIAKMT2AMEN1
SCHEMBL13702282 0.79 SMN1; SMN2 (0.59) ALDH1A1HPGDCHIAKMT2AMEN1
SCHEMBL30267808 0.79 CHIA (0.55) KDM4EALDH1A1HPGDHSD17B10CHIA
SCHEMBL13687262 0.79 NAPRT (0.56) KDM4EHPGDCHIAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC KDM4E 1828/4885ALDH1A1 1414/4885HPGD 1361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.